I won't claim to know what the hell is going on with this

New Post Public Reply Private Reply Replies (3) Message Board
Respert24
884
I won't claim to know what the hell is going on with this deregistration of shares. Heck, I'm not even comfortable typing "deregistration". My brain says it should be unregistration, which my computer immediately informs me is incorrect.

But what I do know is you can google those filing numbers to see why they stick out from the hundred other filings over the last few years.

I did for the first three on the list, and they're all related to offerings for accredited investors. The third is streeterville (Fife).

When I took a glance at the last two they were aggregated data across multiple offerings, and scrolling down there were tables of investors and what they had before and after they sold, or exercised warrants, or whatever. I remember looking at these at the time out of curiosity about who would or wouldn't be on the list, along with who was holding and who was bailing.

Cytodyn is clearly stating with these new amendment filings that they're deregistering UNSOLD shares related to these offerings. This could mean 75 shares, or it could be millions. I just doubt it's a shit ton because Cytodyn has needed to fund operations without revenue year after year and it would be surprising if they were leaving tons of shares on the table every time they had an offering.

What I do know is that they aren't deregistering every last share associated with these offerings. Just the unsold shares. If you venture over to reddit or stocktwits you'll see numerous references to Cytodyn getting back almost 300 million shares (the total of all these filings) as if we've just reduced shares outstanding by that amount. Not a chance. Cytodyn almost certainly sold the majority of those shares to keep the lights on and the LL train moving. We'll drop by what is likely a miniscule, insubstantial amount.

So what does this all mean?

Well, I would highly doubt it's bankruptcy. Not only did they just raise some operating cash, but every time you see bankruptcy discussions you'll see "after declaring bankruptcy" because, if I'm not mistaken, you file for bankruptcy protection before you do anything else. You know, so you're protected. Cytodyn has not declared bankruptcy. Not to mention all the planning, additions to the scientific board, etc.

Also, why would they not do this for every last offering they've ever had? I've been invested for four years and I don't recall ever seeing an amendment like this filed. Why now, and why these specific offerings/filings?

Is it related to some sort of merger or acquisition?

I mean, I guess it's possible that they're cleaning up some of the books to make things right for a partner or suitor. But considering the number of shares coming back are likely insubstantial, what's the big whoop? Though I could get with an explanation that they're going to need every last share to offer to a partner as part of a deal to move an indication forward. Maybe that's all it is. They only have so many shares available to offer anyone looking to make an investment in our company as part of a partnership.

We also have a Nash trial they're anticipating starting soon, though that was lifted after the hold and after the rebranding, if I remember the last call correctly. I think Cyrus was listing things in order of how they'd go down. Hold lifted, rebranding, start a Nash trial.

So I'm leaning toward it having to do with either the hold or the rebranding.

Perhaps we can't have registered, but unused, shares of CYDY floating around when the name is changed to something snazzy like RESP or RSPT. Like, if the share is owned it transitions to the new name, but if it's registered and unowned it gets lost in the shuffle unless you deregister or offer them right quick.

You know, now that I type that out I'm thinking it's the reason. I have no historical data or precedence for believing this, just my gut. Which, if I'm being honest, has been wrong A LOT.

I don't see why a hold being lifted would make a lick of difference for these shares.

Yep, I think we've got it.

The bonus would be they wouldn't rebrand with the company on a hold.

So common sense says that the hold is lifted and this amendment allows the company to rebrand, name their CEO, launch a Nash trial, and maybe sign on a partner.

Or not.

But if it happens like I suggested I'll expect each of you to praise my intelligence and problem solving skills. Otherwise, let the below "IMO" stand as a get out of jail free card if I'm way the hell off.

Oh, and the second most likely scenario is they need these shares to offer to a partnership. I get points for that if it happens too. #Points

All of this is IMO, of course.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie Knepp Joins Exceptional Women Alliance

Updated Category News Views 98

A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...

Continue Reading
Curaleaf Eyes Aurora Amid Alternative from Organigram

Updated Category News Views 65

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

Continue Reading
Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Africa-Caribbean Trade Potential: A $1.65B Opportunity

Updated Category News Views 11

Untapped Opportunities Between Africa and the Caribbean Who's ready to shake up the trade game between Africa and the Caribbean? According to a fresh-off-the-press report from the International Trade Centre (ITC) and Afreximbank, we could be looking at a whopping $1.65 billion in annual trade between these two regions by 2030. That's right, a billion with a 'B'. But let...

Continue Reading
SYNA, CBNK, SSTI Deals: Fair Play for Shareholders?

Updated Category News Views 29

Are Shareholder Interests Truly Represented? Let's dive into the murky waters stirred up by Halper Sadeh LLC's probe into three pivotal transactions involving Synaptics Incorporated (NASDAQ: SYNA), Capital Bancorp, Inc. (NASDAQ: CBNK), and SoundThinking, Inc. (NASDAQ: SSTI). Each of these deals has shareholders wondering if they're getting the short end of the stick while...

Continue Reading
OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 44

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading
AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 56

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
Yum China Delivers Strong Q3 2026 Results Again

Updated Category News Views 70

A Steady March Forward for Yum China Yum China's third-quarter results reveal a company moving like a well-oiled machine, even in a turbulent market. A revenue uptick of 8% is no small feat, especially when operating under the weight of a 3% rise in system sales that neatly sidesteps the usual foreign exchange hiccups. This ain't just about keeping the lights on; it's...

Continue Reading
Massimo Debuts 1500 UTV Line at 2026 SEMA Show

Updated Category News Views 88

Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...

Continue Reading
APTIM Welcomes Chuck Prow to Lead Strategic Growth

Updated Category News Views 89

Chuck Prow Steps Into the CEO Role at APTIM It ain't every day that a seasoned veteran like Chuck Prow takes the helm at a company shaping the backbone of society. Yet here we are, seeing this gritty player onboard APTIM, a name synonymous with high-stakes environmental and resilience consulting. On November 9, with the baton officially passed from Mark Fallon, it's clear...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Albemarle's Recent Options Trading Trends

Updated Category News Views 134

Understanding Albemarle's Options Dynamics Investors holding significant capital have recently adopted an optimistic outlook on Albemarle (NYSE: ALB). It's important for retail traders to stay informed about these trends. Recent Trading Activity Overview Today, we examined notable trades reflected in publicly available options history. Considering the scale of these...

Continue Reading
Investigating Janus International Group, Inc.: What Investors Should Know

Updated Category News Views 283

Investigation into Janus International Group, Inc. Attorney Advertising - Recently, Bronstein, Gewirtz & Grossman, LLC announced an investigation into Janus International Group, Inc. (NYSE: JBI). As investors of Janus securities, it is essential to stay informed about the potential claims that may arise from this investigation. Key Financial Results Janus released...

Continue Reading
Inventus Mining Secures $600,000 in Strategic Funding Round

Updated Category News Views 26

Inventus Mining Completes Successful Financing Inventus Mining Corp. (TSX VENTURE: IVS) is thrilled to announce the closing of a significant non-brokered private placement financing, successfully raising $600,000 by issuing 15 million units at a price of $0.04 each. This funding round aims to support the development of the Pardo Project and further corporate initiatives,...

Continue Reading
Key Insights from Recent Insider Trades and Company Moves

Updated Category News Views 167

Recent Trends in Insider Trading Activities The world of insider trading provides crucial insight into the sentiments surrounding company performance. Understanding these activities can inform investors about potential shifts in a company's trajectory. Here, we highlight some of the notable insider purchases and sales that have occurred recently. Significant Insider...

Continue Reading
Wolfers Critiques S&P 500 Focus as Misguided Economics

Updated Category News Views 145

Understanding Economic Narratives Beyond the S&P 500 In the landscape of financial discussions, the S&P 500 often steals the spotlight. However, University of Michigan professor Justin Wolfers warns that this obsession may reflect a misunderstanding of economic realities. He encourages individuals to look beyond sensational headlines and consider the broader picture of...

Continue Reading